Potential proischemic effect of early enalapril in hypotension-prone patients with acute myocardial infarction

Cardiology (Switzerland)

Volumn 88, Issue 3, 1997, Pages 285-291

  Sogaard, Peter ^a   Thygesen, Kristian ^a   Søgaard, Peter ^a   Peter Sand, Niels ^a   Feldager, Svend ^b   Tingsted, Lisbeth ^b   Sigurd, Bjame ^b   Duedahl, Peter ^c   Hage Rup, Leif ^c   Guul, Sven Jøm ^d   Hvidt, Steffen ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b the Nykøbing Hospital   (United States)

^c HOLSTEBRO HOSPITAL   (Denmark)

^d LILLEBAELT HOSPITAL   (Denmark)

Author keywords

ACE inhibition; Hypotension; Myocardial infarction; Myocardial ischemia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HOLTER MONITORING; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; ENALAPRIL; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION, ORTHOSTATIC; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RECURRENCE;

EID: 0030957662     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177344     Document Type: Article

References (19)

1. Pfeffer MA. Braunwald E. Moye LA. Basta L. Brown EJ Jr. Cuddy TE. Davis BR. Geltman EM. Goldman S. Fiaker GC. Klein M. Lamas GA. Packer M. Rouleau J. Rouleau JL. Rutherford J. Wertheimer JH. Hawkins CM: Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992:327: 669-677.
2. The Acute Infarction Ramipril Efficacy Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.
3. Sogaard P. Gotzsche CO. Ravkilde J. Thygesen K: Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation 1993;87:1093-1099.
4. Sogaard P, Gotzsche CO. Ravkilde J. Norgaard A, Thygesen K: Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction: Effect of intervention with captopril. Circulation 1994:90:101-107.
5. Nabel EG. Topol EJ. Galcana A: A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol 1992:17: 467-473.
6. Ertl G, Kloner RA. Alexander RW, Braunwald E: Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 1982:65:40-48.
7. Hock CE. Ribeiro LOT. Lefer AM: Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. Am Heart J 1985:109: 222-228.
8. van Gilst WH. dc Graeff PA. Wesseling H. dc Langen CDJ: Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting inhibitors: A comparison of captopril, enalapril and HOE 498. J Car-diovasc Pharmacol 1986:8:722-728.
9. Kingnta JH. van Gilst WH. Peels CH. Dam-brink JHE, Verheugt FWA, Wielenga RP for the CATS Investigators: Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Eur Heart J 1994;15:898-907.
10. Swedberg K. Held P. Kjckshus J. Rasmussen K. Ryden L. Wedel H. on behalf of the CONSENSUS II Study Group: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 1992;327:678-684.
11. GISSI-3 Study Group: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 weeks mortality and ventricular function after acute myocardial infarction. Lancet 1994:343:1115-1122.
12. Ambrosioni E. Borghi C, Magnani B. for the SMILE Study Investigators: The effect of the angiotensin converting enzyme inhibitor zofe-nopril on mortality and morbidity after anterior mvocardial infarction. N Engl J Med 1995; 332:80-85.
13. ISIS-4: A randomized factorial trial assessing early oral captopril. oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995:345:669-685.
14. Chinese Cardiac Study Collaborative Group: Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995:345:686-687.
15. Lee KL, Woodlief LH. Topol EJ, Weaver D, Betria A, Col J. Simoons M. Aylward P. van de Werf F. CalifT RM for the GUSTO-1 Investigators: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation 1995:91:1659-1668.
16. Braunwald E, Kloner RA: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
17. Reid JL. MacFadyen RJ. Squire IB. Lees KR: Angiotensin-converting enzyme inhibitors in heart failure: Blood pressure changes after the first dose. Am Heart J 1993:126:794-797.
18. Bonarjee WS. Carstcnsen S. Caidahl K. Nils-en DWT. Edner M. Berning J, on behalf of the CONSENSUS II Multi-Echo Study Group: Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy. Am J Cardiol 1993;72: 1004-1009.
19. Stevenson RN. Wilkinson P, Marchant BD. Kulasegaram R. Timmis AD: Relative value of clinical variables, treadmill stress testing, and Holler ST monitoring for postinfarction risk stratification. Am J Cardiol 1994;74:221-225.